Drug recall · December 18, 2019
Amantadine Hydrochloride Tablets recall
Why: Presence of Foreign Substance: Presence of a foreign object in a single tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.
- Lots / codes
Lot #: NT119005A, Exp 07/2021
- Quantity
- 1,824 bottles
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Nationwide in the USA.
- Initiated
- December 2, 2019 · Voluntary: Firm initiated
- Classified
- December 6, 2019
- Reported
- December 18, 2019
- Ended
- October 14, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amantadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.